Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 8th February 2012
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
VMD clarifies MRL for Altrenogest
Shorter withdrawal period set

The Veterinary Medicines Directorate (VMD) have revised the maximum residue limit (MRL) for Altrenogest, a hormone used in commercial equine breeding, after careful consideration of the relevant scientific data. The revised MRL is higher than was previously the case, although it has been deemed necessary that existing residue studies will need to be re-examined. Also, it is likely that the withdrawal periods of relevant products across the EU will be set to a limit of 15 days by a European Council Directive.

The process to establish the revised withdrawal periods has started, and is currently being co-ordinated across the European Union. It is hoped that all new batches of Altrenogest-containing products intended for the UK market will specify the shorter withdrawal periods by the end of 2012. In the meantime, these products can remain on the market.

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.